Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$75.41 - $84.21 $2.33 Million - $2.6 Million
-30,870 Closed
0 $0
Q2 2024

Aug 14, 2024

SELL
$68.26 - $76.19 $3.76 Million - $4.19 Million
-55,030 Reduced 64.06%
30,870 $2.35 Million
Q3 2023

Nov 03, 2023

BUY
$61.9 - $72.77 $2.48 Million - $2.91 Million
40,000 Added 87.15%
85,900 $5.74 Million
Q3 2022

Jan 10, 2025

SELL
$49.9 - $57.32 $1.19 Million - $1.37 Million
-23,900 Reduced 34.24%
45,900 $2.4 Million
Q3 2022

Nov 10, 2022

SELL
$49.9 - $57.32 $1.19 Million - $1.37 Million
-23,900 Reduced 34.24%
45,900 $2.4 Million
Q1 2022

Jan 10, 2025

BUY
$48.27 - $65.25 $3.37 Million - $4.55 Million
69,800 New
69,800 $3.89 Million
Q2 2021

Jan 10, 2025

SELL
$62.12 - $74.2 $956,648 - $1.14 Million
-15,400 Reduced 18.08%
69,800 $5.13 Million
Q2 2021

Aug 06, 2021

SELL
$62.12 - $74.2 $956,648 - $1.14 Million
-15,400 Reduced 18.08%
69,800 $5.13 Million
Q1 2021

Jan 10, 2025

BUY
$57.98 - $73.08 $4.94 Million - $6.23 Million
85,200 New
85,200 $5.23 Million
Q1 2021

May 14, 2021

BUY
$57.98 - $73.08 $881,296 - $1.11 Million
15,200 Added 21.71%
85,200 $5.23 Million
Q4 2020

Jan 10, 2025

BUY
$62.61 - $71.29 $4.38 Million - $4.99 Million
70,000 New
70,000 $4.99 Million
Q4 2020

Feb 12, 2021

SELL
$62.61 - $71.29 $125,220 - $142,580
-2,000 Reduced 2.78%
70,000 $4.99 Million
Q3 2020

Nov 12, 2020

BUY
$51.39 - $72.41 $806,823 - $1.14 Million
15,700 Added 27.89%
72,000 $5.01 Million
Q2 2020

Aug 13, 2020

BUY
$39.55 - $54.65 $1.25 Million - $1.73 Million
31,600 Added 127.94%
56,300 $2.98 Million
Q4 2019

Feb 13, 2020

BUY
$36.66 - $41.78 $905,501 - $1.03 Million
24,700 New
24,700 $1 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.26B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.